Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation
- PMID: 29936228
- DOI: 10.1016/j.jmgm.2018.05.010
Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation
Abstract
In an attempt to identify potential COX-2 inhibitors, a multi-step virtual screening strategy was performed on a series of compounds. For this purpose, ZINC database was screened on the basis of 50% structural similarity with celecoxib and indomethacin as the representative of COX-2 and COX-1/COX-2 inhibitors, respectively. Selected molecules were subjected to various filters such as Lipinski's rule of five and also several ADME parameters. Toxicity risk of molecules was approximated via in silico methods. Moreover, COX-2 inhibitory activities of the selected compounds were predicted using PASS program. Molecular docking was performed to improve the accuracy of screening and also to find the details of the interactions of the hit compounds with the active site. Finally, MD simulations on top-ranked structures ZINC_1130464, ZINC_3181760, ZINC_33402495 and celecoxib were carried out with COX-2. Furthermore, RMSD, RMSF, hydrogen binds, Rg and energy analysis during MD simulation certainly indicated the stable binding of selected compounds with COX-2 structure. Moreover, docking and MD results revealed that hydrophobic contacts and optimum hydrogen bonds were determinant factors in the interactions of in silico hits and COX-2.
Keywords: ADMET; COX-2 inhibitor; Molecular dynamic; PASS; Virtual screening.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacophore modelling, docking and molecular dynamic simulation studies in the discovery of potential human renin inhibitors.J Mol Graph Model. 2022 Nov;116:108272. doi: 10.1016/j.jmgm.2022.108272. Epub 2022 Jul 13. J Mol Graph Model. 2022. PMID: 35932508
-
Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.Interdiscip Sci. 2019 Jun;11(2):153-169. doi: 10.1007/s12539-017-0244-5. Epub 2017 Dec 13. Interdiscip Sci. 2019. PMID: 29236213
-
An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.Daru. 2021 Dec;29(2):311-320. doi: 10.1007/s40199-021-00408-6. Epub 2021 Aug 20. Daru. 2021. PMID: 34415547 Free PMC article.
-
Roles of Virtual Screening and Molecular Dynamics Simulations in Discovering and Understanding Antimalarial Drugs.Int J Mol Sci. 2023 May 26;24(11):9289. doi: 10.3390/ijms24119289. Int J Mol Sci. 2023. PMID: 37298256 Free PMC article. Review.
-
VSPrep: A KNIME Workflow for the Preparation of Molecular Databases for Virtual Screening.Curr Med Chem. 2020;27(38):6480-6494. doi: 10.2174/0929867326666190614160451. Curr Med Chem. 2020. PMID: 31242833 Review.
Cited by
-
Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.J Biomol Struct Dyn. 2022 Mar;40(5):2067-2081. doi: 10.1080/07391102.2020.1835729. Epub 2020 Oct 22. J Biomol Struct Dyn. 2022. PMID: 33089730 Free PMC article.
-
High-throughput screening of natural antiviral drug candidates against white spot syndrome virus targeting VP28 in Penaeus monodon: Computational drug design approaches.J Genet Eng Biotechnol. 2025 Mar;23(1):100455. doi: 10.1016/j.jgeb.2024.100455. Epub 2024 Dec 28. J Genet Eng Biotechnol. 2025. PMID: 40074429 Free PMC article.
-
Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2.J Biomol Struct Dyn. 2021 Oct;39(16):6290-6305. doi: 10.1080/07391102.2020.1796804. Epub 2020 Jul 28. J Biomol Struct Dyn. 2021. PMID: 32720571 Free PMC article.
-
Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity.Curr Issues Mol Biol. 2022 Jan 15;44(1):383-408. doi: 10.3390/cimb44010028. Curr Issues Mol Biol. 2022. PMID: 35723407 Free PMC article.
-
HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies.J Tradit Complement Med. 2019 Aug 1;10(4):396-404. doi: 10.1016/j.jtcme.2019.08.002. eCollection 2020 Jul. J Tradit Complement Med. 2019. PMID: 32695657 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials